|
1
|
Wallentin L, Kristensen SD, Anderson JL,
et al: How can we optimize the processes of care for acute coronary
syndromes to improve outcomes? Am Heart J. 168:622–631. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Segers VF and Lee RT: Stem-cell therapy
for cardiac disease. Nature. 451:937–942. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bai X, Yan Y, Song YH, et al: Both
cultured and freshly isolated adipose tissue-derived stem cells
enhance cardiac function after acute myocardial infarction. Eur
Heart J. 31:489–501. 2010. View Article : Google Scholar
|
|
4
|
Strioga M, Viswanathan S, Darinskas A,
Slaby O and Michalek J: Same or not the same? Comparison of adipose
tissue-derived versus bone marrow-derived mesenchymal stem and
stromal cells. Stem Cells Dev. 21:2724–2752. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harasymiak-Krzyżanowska I, Niedojadło A,
Karwat J, et al: Adipose tissue-derived stem cells show
considerable promise for regenerative medicine applications. Cell
Mol Biol Lett. 18:479–493. 2013. View Article : Google Scholar
|
|
6
|
Konno M, Hamabe A, Hasegawa S, et al:
Adipose-derived mesenchymal stem cells and regenerative medicine.
Dev Growth Differ. 55:309–318. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mazo M, Gavira JJ, Pelacho B and Prosper
F: Adipose‑derived stem cells for myocardial infarction. J.
Cardiovasc Transl Res. 4:145–153. 2011. View Article : Google Scholar
|
|
8
|
Chavakis E and Dimmeler S: Homing of
progenitor cells to ischemic tissues. Antioxid Redox Signal.
15:967–980. 2011. View Article : Google Scholar
|
|
9
|
Li Q, Zhang A, Tao C, Li X and Jin P: The
role of SDF-1-CXCR4/CXCR7 axis in biological behaviors of adipose
tissue-derived mesenchymal stem cells in vitro. Biochem Biophys Res
Commun. 441:675–680. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cencioni C, Capogrossi MC and Napolitano
M: The SDF-1/CXCR4 axis in stem cell preconditioning. Cardiovasc
Res. 94:400–407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhuang Y, Chen X, Xu M, Zhang LY and Xiang
F: Chemokine stromal cell-derived factor 1/CXCL12 increases homing
of mesenchymal stem cells to injured myocardium and
neovascularization following myocardial infarction. Chin Med J
(Engl). 122:183–187. 2009.
|
|
12
|
Haider H, Jiang S, Idris NM and Ashraf M:
IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow
stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4
signaling to promote myocardial repair. Circ Res. 103:1300–1308.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cho HH, Kyoung KM, Seo MJ, Kim YJ, Bae YC
and Jung JS: Overexpression of CXCR4 increases migration and
proliferation of human adipose tissue stromal cells. Stem Cells
Dev. 15:853–864. 2006. View Article : Google Scholar
|
|
14
|
Wang K, Zhao X, Kuang C, et al:
Overexpression of SDF-1α enhanced migration and engraftment of
cardiac stem cells and reduced infarcted size via CXCR4/PI3K
pathway. PLoS One. 7:e439222012. View Article : Google Scholar
|
|
15
|
Chang G, Zhang D, Yu H, et al:
Cardioprotective effects of exenatide against oxidative
stress-induced injury. Int J Mol Med. 32:1011–1020. 2013.PubMed/NCBI
|
|
16
|
Li Y, Cao X, Li LX, et al: beta-Cell Pdx1
expression is essential for the glucoregulatory, proliferative, and
cytoprotective actions of glucagon-like peptide-1. Diabetes.
54:482–491. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kang HM, Kang Y, Chun HJ, Jeong JW and
Park C: Evaluation of the in vitro and in vivo angiogenic effects
of exendin-4. Biochem Biophys Res Commun. 434:150–154. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miyahara Y, Nagaya N, Kataoka M, et al:
Monolayered mesenchymal stem cells repair scarred myocardium after
myocardial infarction. Nat Med. 12:459–465. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen S, Liu J, Liu X, et al: Panax
notoginseng saponins inhibit ischemia-induced apoptosis by
activating PI3K/Akt pathway in cardiomyocytes. J Ethnopharmacol.
137:263–270. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma X, Gao Y, Fan Y, et al: Overexpression
of E2F1 promotes tumor malignancy and correlates with TNM stages in
clear cell renal cell carcinoma. PLoS One. 8:e734362013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang D, Fan GC, Zhou X, et al:
Over-expression of CXCR4 on mesenchymal stem cells augments
myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol.
44:281–292. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bonaros N, Sondermeijer H, Wiedemann D, et
al: Downregulation of the CXC chemokine receptor 4/stromal
cell-derived factor 1 pathway enhances myocardial
neovascularization, cardiomyocyte survival, and functional recovery
after myocardial infarction. J Thorac Cardiovasc Surg. 142:687–696.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang YB, Liu YF, Lu XT, et al: Rehmannia
glutinosa extract activates endothelial progenitor cells in a rat
model of myocardial infarction through a SDF-1 α/CXCR4 cascade.
PLoS One. 8:e543032013. View Article : Google Scholar
|
|
24
|
Yang J, Zhang H, Zhao L, Chen Y, Liu H and
Zhang T: Human adipose tissue-derived stem cells protect impaired
cardiomyocytes from hypoxia/reoxygenation injury through
hypoxia-induced paracrine mechanism. Cell Biochem Funct.
30:505–514. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Qu J, Shelat H, Gao S, Wassler M and
Geng YJ: Clusterin induces CXCR4 expression and migration of
cardiac progenitor cells. Exp Cell Res. 316:3435–3442. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Timmers L, Henriques JP, de Kleijn DP, et
al: Exenatide reduces infarct size and improves cardiac function in
a porcine model of ischemia and reperfusion injury. J Am Coll
Cardiol. 53:501–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Strauer BE and Steinhoff G: 10 years of
intracoronary and intramyocardial bone marrow stem cell therapy of
the heart: from the methodological origin to clinical practice. J
Am Coll Cardiol. 58:1095–1104. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Templin C, Lüscher TF and Landmesser U:
Cell‑based cardiovascular repair and regeneration in acute
myocardial infarction and chronic ischemic cardiomyopathy-current
status and future developments. Int J Dev Biol. 55:407–417. 2011.
View Article : Google Scholar
|
|
29
|
Krane M, Wernet O and Wu SM: Promises and
pitfalls in cell replacement therapy for heart failure. Drug Discov
Today Dis Mech. 7:e109–e115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dow J, Simkhovich BZ, Kedes L and Kloner
RA: Washout of transplanted cells from the heart: a potential new
hurdle for cell transplantation therapy. Cardiovasc Res.
67:301–307. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Askari AT, Unzek S, Popovic ZB, et al:
Effect of stromal-cell-derived factor 1 on stem-cell homing and
tissue regeneration in ischaemic cardiomyopathy. Lancet.
362:697–703. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rosenkranz K, Kumbruch S, Lebermann K, et
al: The chemokine SDF-1/CXCL12 contributes to the ‘homingʼ of
umbilical cord blood cells to a hypoxic-ischemic lesion in the rat
brain. J Neurosci Res. 88:1223–1233. 2010.
|
|
33
|
Stokman G, Stroo I, Claessen N, Teske GJ,
Florquin S and Leemans JC: SDF-1 provides morphological and
functional protection against renal ischaemia/reperfusion injury.
Nephrol Dial Transplant. 25:3852–3859. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Penn MS: SDF-1:CXCR4 axis is fundamental
for tissue preservation and repair. Am J Pathol. 177:2166–2168.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sotsios Y, Whittaker GC, Westwick J and
Ward SG: The CXC chemokine stromal cell-derived factor activates a
Gi-coupled phosphoinositide 3-kinase in T lymphocytes. J Immunol.
163:5954–5963. 1999.PubMed/NCBI
|
|
36
|
Hillyer P, Mordelet E, Flynn G and Male D:
Chemokines, chemokine receptors and adhesion molecules on different
human endothelia: discriminating the tissue-specific functions that
affect leucocyte migration. Clin Exp Immunol. 134:431–441. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Alsayed Y, Ngo H, Runnels J, et al:
Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent
migration and homing in multiple myeloma. Blood. 109:2708–2717.
2007.
|
|
38
|
Honczarenko M, Le Y, Swierkowski M, Ghiran
I, Glodek AM and Silberstein LE: Human bone marrow stromal cells
express a distinct set of biologically functional chemokine
receptors. Stem Cells. 24:1030–1041. 2006. View Article : Google Scholar
|
|
39
|
Cheng Z, Ou L, Zhou X, et al: Targeted
migration of mesenchymal stem cells modified with CXCR4 gene to
infarcted myocardium improves cardiac performance. Mol Ther.
16:571–579. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shi M, Li J, Liao L, et al: Regulation of
CXCR4 expression in human mesenchymal stem cells by cytokine
treatment: role in homing efficiency in NOD/SCID mice.
Haematologica. 92:897–904. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tahrani AA, Bailey CJ, Del Prato S and
Barnett AH: Management of type 2 diabetes: new and future
developments in treatment. Lancet. 378:182–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Davidson MH: Cardiovascular effects of
glucagonlike peptide-1 agonists. Am J Cardiol. 108:33B–41B. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Monji A, Mitsui T, Bando YK, Aoyama M,
Shigeta T and Murohara T: Glucagon-like peptide-1 receptor
activation reverses cardiac remodeling via normalizing cardiac
steatosis and oxidative stress in type 2 diabetes. Am J Physiol
Heart Circ Physiol. 305:H295–H304. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hu X, Dai S, Wu WJ, et al: Stromal cell
derived factor-1 alpha confers protection against myocardial
ischemia/reperfusion injury: role of the cardiac stromal cell
derived factor-1 alpha CXCR4 axis. Circulation. 116:654–663. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Huang C, Gu H, Zhang W, Manukyan MC, Shou
W and Wang M: SDF-1/CXCR4 mediates acute protection of cardiac
function through myocardial STAT3 signaling following global
ischemia/reperfusion injury. Am J Physiol Heart Circ Physiol.
301:H1496–H1505. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hausenloy DJ, Lecour S and Yellon DM:
Reperfusion injury salvage kinase and survivor activating factor
enhancement prosurvival signaling pathways in ischemic
postconditioning: two sides of the same coin. Antioxid Redox
Signal. 14:893–907. 2011. View Article : Google Scholar
|
|
47
|
Zou YR, Kottmann AH, Kuroda M, Taniuchi I
and Littman DR: Function of the chemokine receptor CXCR4 in
haematopoiesis and in cerebellar development. Nature. 393:595–599.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Peled A, Petit I, Kollet O, et al:
Dependence of human stem cell engraftment and repopulation of
NOD/SCID mice on CXCR4. Science. 283:845–848. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ji JF, He BP, Dheen ST and Tay SS:
Interactions of chemokines and chemokine receptors mediate the
migration of mesenchymal stem cells to the impaired site in the
brain after hypoglossal nerve injury. Stem Cells. 22:415–427. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Odemis V, Boosmann K, Dieterlen MT and
Engele J: The chemokine SDF1 controls multiple steps of myogenesis
through atypical PKCzeta. J Cell Sci. 120:4050–4059. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mangi AA, Noiseux N, Kong D, et al:
Mesenchymal stem cells modified with Akt prevent remodeling and
restore performance of infarcted hearts. Nat Med. 9:1195–1201.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Gnecchi M, Zhang Z, Ni A and Dzau VJ:
Paracrine mechanisms in adult stem cell signaling and therapy. Circ
Res. 103:1204–1219. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
González N, Acitores A, Sancho V, Valverde
I and Villanueva-Peñacarrillo ML: Effect of GLP-1 on glucose
transport and its cell signalling in human myocytes. Regul Pept.
126:203–211. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liu N, Tian J, Cheng J and Zhang J:
Migration of CXCR4 gene-modified bone marrow-derived mesenchymal
stem cells to the acute injured kidney. J Cell Biochem.
114:2677–2689. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kim SJ, Lee Y, Kim NY, et al: Pancreatic
adenocarcinoma upregulated factor, a novel endothelial activator,
promotes angiogenesis and vascular permeability. Oncogene.
32:3638–3647. 2013. View Article : Google Scholar
|
|
56
|
McCaig AM, Cosimo E, Leach MT and Michie
AM: Dasatinib inhibits CXCR4 signaling in chronic lymphocytic
leukaemia cells and impairs migration towards CXCL12. PLoS One.
7:e489292012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Liu H, Xue W, Ge G, et al: Hypoxic
preconditioning advances CXCR4 and CXCR7 expression by activating
HIF-1α in MSCs. Biochem Biophys Res Commun. 401:509–515. 2010.
View Article : Google Scholar : PubMed/NCBI
|
